Franklin Resources’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-1,386,447
Closed -$14.2M 1543
2016
Q3
$14.2M Sell
1,386,447
-3,254,302
-70% -$35.4M 0.01% 893
2016
Q2
$60.6M Buy
4,640,749
+267,289
+6% +$3.5M 0.03% 471
2016
Q1
$48.1M Sell
4,373,460
-81,100
-2% -$721K 0.03% 541
2015
Q4
$41M Hold
4,454,560
0.02% 612
2015
Q3
$30.9M Buy
4,454,560
+178,900
+4% +$1.53M 0.02% 719
2015
Q2
$42M Buy
4,275,660
+111,100
+3% +$1.01M 0.02% 657
2015
Q1
$36.9M Buy
4,164,560
+309,600
+8% +$2.47M 0.02% 710
2014
Q4
$33.8M Sell
3,854,960
-423,300
-10% -$3.43M 0.02% 736
2014
Q3
$29.5M Sell
4,278,260
-407,282
-9% -$2.44M 0.01% 754
2014
Q2
$24.6M Buy
4,685,542
+1,019,282
+28% +$4.96M 0.01% 810
2014
Q1
$16.7M Buy
3,666,260
+147,500
+4% +$712K 0.01% 906
2013
Q4
$17.7M Buy
3,518,760
+84,600
+2% +$407K 0.01% 848
2013
Q3
$17.4M Sell
3,434,160
-284,000
-8% -$1.58M 0.01% 843
2013
Q2
$18.4M Buy
+3,718,160
New +$17.7M 0.01% 781

Other funds holding SCLN

Franklin Resources's SCLN Position: Q4 2016 in Review

Franklin Resources sold out of Sciclone Pharmaceuticals Inc (SCLN) in Q4 2016, closing a stake of 1,386,447 shares — an estimated $14.2M sold.

Franklin Resources first reported a position in SCLN in Q2 2013 and held it in 14 quarters. The position peaked at $60.6M in Q2 2016. 153 funds tracked by Wall St. Rank hold SCLN as of Q4 2016.

  • Franklin Resources reported no remaining Sciclone Pharmaceuticals Inc position as of Q4 2016 after selling out during the quarter.
  • Franklin Resources sold 1,386,447 Sciclone Pharmaceuticals Inc shares in Q4 2016, an estimated $14.2M.
  • Franklin Resources first reported a position in Sciclone Pharmaceuticals Inc in Q2 2013 and held it in 14 quarters.
  • Franklin Resources's Sciclone Pharmaceuticals Inc position peaked at $60.6M in Q2 2016.
  • 153 funds tracked by Wall St. Rank held Sciclone Pharmaceuticals Inc as of Q4 2016.

Based on Franklin Resources's 13F filing for Q4 2016, filed 14 Feb 2017.